YanAn Bicon Pharmaceutical Listed Company

002411

CNE100000PJ4

YanAn Bicon Pharmaceutical Listed Company Announces Executive Changes

March 10, 2022 at 02:37 pm EST

YanAn Bicon Pharmaceutical Listed Company announced that at the Extraordinary General Meeting held on 09 March 2022, approved Independent directors' leaving their posts upon the expiration of their tenure and by-election of independent directors, cumulative voting system applicable: Tian Qian and Zhang Baishuan.

Latest news about YanAn Bicon Pharmaceutical Listed Company

YanAn Bicon Pharma Delists From Shenzhen Exchange	23-07-12	MT
YanAn Bicon Pharma Vice Chairman Resigns	23-07-04	MT
YanAn Bicon Pharmaceutical Listed Company(SZSE:002411) dropped from Shenzhen Stock Exchange Composite Index	23-06-16	CI
YanAn Bicon Pharmaceutical Listed Company(SZSE:002411) dropped from Shenzhen Stock Exchange A Share Index	23-06-16	CI
YanAn Bicon Pharmaceutical Listed Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
YanAn Bicon Pharmaceutical Listed Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
YanAn Bicon Pharma to Spend 2.3 Billion Yuan in Expansion Projects	23-02-22	MT
Yanan Bicon Pharmaceutical Listed Company Announces Resignation of Wang Zidong as Chairman of the Supervisory Committee	23-02-21	CI
YanAn Bicon Pharmaceutical Listed Company Approves Election of Ma Bing as Non-Independent Director	22-12-30	CI
Announcement on Resolutions of the Seventh Extraordinary General Meeting of Shareholders in 2022	22-12-29	CI
Xuzhou Beisong Industrial Investment Co., Ltd. entered into an Equity Transfer Agreement to acquire Xuzhou Beimeng Logistics Co., Ltd. from YanAn Bicon Pharmaceutical Listed Company for CNY 0 million.	22-12-28	CI
The Shareholder Mr. Zhou Xinji Submited Proposal Regarding the Sale of Partial Assets and Equity of the Issuer YanAn Bicon Pharmacautical's Subsidiary	22-12-15	CI
Nanjing Jiuzhou Xingji New Materials Co., Ltd. completed the acquisition of Jiuzhou Xingi Technology Co., Ltd. from YanAn Bicon Pharmaceutical Listed Company.	22-12-14	CI
Chinese Shares Finish Lower; YanAn Bicon Falls 5% After Selling Unit	22-11-24	MT
YanAn Bicon Pharma Sells Composite Materials Unit For $294 Million	22-11-23	MT
Nanjing Jiuzhou Xingji New Materials Co., Ltd. agreed to acquire Jiuzhou Xingi Technology Co., Ltd. from YanAn Bicon Pharmaceutical Listed Company for CNY 2.1 Billion.	22-11-23	CI
YanAn Bicon Pharmaceutical to Sell Tech Firm to Ease Liquidity Pressure	22-11-23	CI
YanAn Bicon Pharmaceutical Listed Company Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
YanAn Bicon Pharma Names New Vice Chairman	22-09-23	MT
YanAn Bicon Pharmaceutical Listed Company Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Shenzhen Exchange Assigns Risk Warning to YanAn Bicon Pharma’s Shares	22-06-30	MT
YanAn Bicon Pharmaceutical Listed Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-29	CI
YanAn Bicon Pharmaceutical Listed Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
YanAn Bicon Pharmaceutical Listed Company Announces Executive Changes	22-03-10	CI
NanHua Bio-medicine Co., Ltd signed a letter of intent to acquire Medicine-related assets from YanAn Bicon Pharmaceutical Listed Company.	21-12-09	CI

Chart YanAn Bicon Pharmaceutical Listed Company

Duration

Period

Chart YanAn Bicon Pharmaceutical Listed Company

More charts

Company Profile

YanAn Bicon Pharmaceutical Listed Company, formerly JiangSu Bicon Pharmaceutical Listed Company, is a China-based company principally engaged in the research and development, manufacture and distribution of medical products, new energy materials and drug intermediates. The Company operates its businesses through three segments. The Pharmaceuticals segment provides circulatory system, digestive system, respiratory system, nervous system and ophthalmic products. The New Materials segment mainly consists of lithium hexafluorophosphate, high-strength and high modulus polyethylene fibers and others. The Pharmaceutical Intermediates segment consists of 7-ADCA, benzaldehyde, 5.5-dimethylhydantion and trichloropyridine. The Company distributes its products mainly in domestic market.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.27B
OTSUKA HOLDINGS CO., LTD.	+24.52%	22.92B
SANDOZ GROUP AG	+20.29%	15.43B
CIPLA LIMITED	+7.48%	12.95B
ZYDUS LIFESCIENCES LIMITED	+42.51%	11.83B
ONO PHARMACEUTICAL CO., LTD.	-8.84%	6.91B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.13%	5.55B

Generic Pharmaceuticals